The aim of this study was to determine the antimicrobial effects of lemongrass essential oil (C. flexuosus) and to determine cytotoxic effects of both test compounds on human dermal fibroblasts. Antimicrobial susceptibility screening was carried out using the disk diffusion method. Antimicrobial resistance was observed in four of five Acinetobacter baumannii strains with two strains confirmed as multi-drug-resistant (MDR). All the strains tested were susceptible to both lemongrass and citral with zones of inhibition varying between 17 to 80 mm. The mean minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of citral (mic—0.14 % and mbc—0.3 % v/v) was lower than that of Lemongrass (mic—0.65 % and mbc—1.1 % v/v) determined using the microtitre plate method. Cell viability using human dermal fibroblasts (HDF; 106-05a) was determined following exposure to both compounds and a control (Grapeseed oil) using the XTT assay and the IC50 determined at 0.095 % (v/v) for citral and 0.126 % (v/v) for lemongrass. Grapeseed oil had no effect on cell viability. Live cell imaging was performed using the LumaScope 500 imaging equipment and changes in HDF cell morphology such as necrotic features and shrinkage were observed. The ability of lemongrass essential oil (EO) and citral to inhibit and kill MDR A. baumannii highlights its potential for use in the management of drug-resistant infections; however, in vitro cytotoxicity does suggest further tests are needed before in vivo or ex vivo human exposure.
The global threat of antimicrobial resistance (AMR) and infections caused by AMR bacteria has raised the need for urgent therapeutic discoveries and improvement of existing infection control and antimicrobial practices. In recent years, the Gram-negative bacterium Acinetobacter baumannii has been identified as a resilient and resistant pathogen (Perez et al. 2007). Outbreaks in hospital and community settings caused by multi-drug-resistant, extensively drug-resistant and pan-drug-resistant A. baumannii have been reported worldwide. According to Vila and Pachon (2011), new approaches and antimicrobial agents are needed for the control of A. baumannii infections as the few existing treatments have not been successful in managing infections caused by A. baumannii.
The failure of existing antibiotics in managing infections caused by AMR organisms has increased interest in alternative treatments. This is demonstrated by the breadth of literature published in the area of natural antimicrobials especially the antimicrobial effects of plant based essential oils (EOs). The effects EOs are wide ranging and include antibacterial, antifungal, antibiofilm, antiparasitic, antioxidant, antiviral, anticancer and many other reported effects; however, the information on bioactivity and toxicity of essential oils is not as extensively studied. Despite this, the commercial use and applications of EOs continues to grow, e.g. EOs are used in household cleaning products, cosmetics, perfumery, insecticides, disinfectant wipes, food and in management of infections in animals.
There are between 400 and 500 commercially produced essential oils (Tisserand and Young 2013) and one EO with a growing reputation is Lemongrass EO of the Cymbopogon species. The antimicrobial effect of whole lemongrass EO has been shown in previous studies with a wide range of in vitro activity including effects against AMR pathogens (Doran et al. 2009; Warnke et al. 2009; Adukwu et al. 2012). The strong antimicrobial activity of lemongrass has been attributed to a high citral content (Marongiu et al. 2006; Adukwu et al. 2012; Kumar et al. 2013; Kpoviessi et al. 2014). Both lemongrass EO and citral are generally regarded as safe (GRAS) for use as flavouring substances and is also an approved compound for use as a food additive and for human consumption (Food and drug Administration 2015a; 2015b).
Generally, cytotoxic activity of EOs and components on human cell lines have been studied with a larger proportion of these studies focusing on the effects of tea tree oil (Söderberg et al. 1996; Lis-Balchin et al. 2000; Hammer et al. 2006; Loughlin et al. 2008; Nielsen 2008). Kpoviessi et al. (2014) investigated the cytotoxic activity of lemongrass EO from four Cymbopogon species; C.citratus, C. giganteus, C. nardus and C. schoenantus against a human non-cancer diploid fibroblast cell line (W138) showing moderate toxicity of C. citratus against this W138 cell line. The cytotoxic effect of C. flexuosus, the EO in focus in our study and known to possess antimicrobial activity, was not determined in the Kpoviessi study, and the effect of the oil on dermal fibroblast is yet to be demonstrated to our knowledge. Citral on the other hand has been reported to cause several adverse reactions such as sensitisation and allergic contact dermatitis (Tisserand and Balacs 1995; Heydorn et al. 2003).
The focus of this study was to investigate the antimicrobial activity of C. flexuosus and citral against A. baumannii and to determine the cytotoxic activity of both C. flexuosus and citral on human fibroblasts which is important due to the growing usage of EOs in household applications and cosmetics as well as proposed usage in health care applications.
Materials and methods
Five A. baumannii strains from the University of the West of England, Bristol, UK, microbiology culture collection were used in this study. These were ATCC® BAA-1709™ (human isolate), ATCC® BAA-1710™ (human isolate), NCTC 12156 (ATCC 19606; type strain), ATCC 17978 (lung infection model; human isolate) and SM 37212, a clinical isolate obtained from the Pathology department at Southmead Hospital, Bristol, UK. The strains were maintained on brain heart infusion (BHI) agar (CM1136; Oxoid Ltd, Basingstoke, UK) and sub-cultured on a weekly basis. For inoculum preparation, single colonies were picked from a BHI agar plate into BHI broth (CM1135; Oxoid Ltd., Basingstoke, UK) and incubated overnight at 37 °C.
EO and component
The lemongrass EO (C. flexuosus) used in this study was donated by Amphora Aromatics, Bristol, UK, whilst citral (95 %; synonym—3,7-dimethyl-2,6-octadienal, geranial and neral mixture; CAS Number 5392–40-5) was purchased from Sigma-Aldrich, Dorset, UK. The EO and citral were stored in a cool dark place and the containers kept tightly closed in a dry and well-ventilated place according to the safety data information.
The disk diffusion assay was used to determine antimicrobial susceptibility of the A. baumannii to a selection of antibiotics (Table 1) using the British Society for Antimicrobial Chemotherapy guidelines, version 13 (2014) and to whole lemongrass EO and citral. Using the agar overlay assay, bacterial lawns were prepared with the inoculum size adjusted to approximately 1.5 × 108 CFU/ml. Ten microliters of lemongrass EO and citral were deposited onto 6-mm filter paper discs before placing them on the surface of Iso-sensitest agar (Oxoid; Basingstoke, UK). The agar plates were then incubated at 37 °C for 24 h and the diameter of the zone of inhibition (ZOI) measured in millimetres using a Vernier calliper. Each experiment was performed in triplicate. The controls were bacterial cultures without treatment.
Minimum inhibitory concentration and minimum bactericidal concentration
The method used in this study for determination of inhibitory and bactericidal activity of both lemongrass EO and citral was similar to that use in Adukwu et al. (2012) with similar concentration ranges 0.03, 0.06, 0.12, 0.5, 1, 2 and 4 % (v/v), and the only difference was the microplate reader. In this study, we used the Tecan Infinite 200 PRO, Reading, UK for optical density measurements. For minimum bactericidal concentration (MBC) determination, 10 μl was taken from each well (treated and untreated) after incubation and spot inoculated on BHI agar and incubated for 24 h at 37 °C. The concentration at which no growth was observed on subculture was determined as the MBC.
Primary cell cultures of human dermal fibroblasts (HDF; 106-05a) were obtained from ECACC (European Collection of Cell Cultures, Porton Down, Sailsbury, UK). HDFs were cultured in DMEM (Sigma, Poole, UK, D6546) supplemented with 10 % (v/v) FBS (Sigma) and 1 % (v/v) GIBCO® GlutaMAX™ (ThermoFisher Scientific, Paisley, UK). Cells were maintained at 37 °C, in a humidified incubator at 5 % CO2 and passaged when 80 % confluent using 0.25 % Gibco® Trypsin-EDTA (ThermoFisher Scientific, Paisley, UK).
In vitro cytotoxicity testing
The XTT assay (X4626 SIGMA, Poole, UK) was used in this study to assess cell viability. The HDFs were plated at 1 × 104 cells/100 μl in sterile 96-well tissue culture microtitre plates and incubated in a humidified atmosphere of 5 % CO2 at 37 °C for 48 h to allow the cells to reach approximately 70 % confluence. The growth medium was discarded and replaced with growth medium containing serial dilutions of lemongrass EO or citral and further incubated for 1 h.
Cell viability was determined using a combination of the tetrazolium compound 2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide (XTT, Sigma) and the electron coupling reagent phenazine methosulphate (PMS, Sigma). Each reagent was prepared separately by dissolving XTT at 1 mg/ml in pre-warmed (55 °C) media and dissolving PMS at 1.53 mg/ml in PBS. To 1 ml of the XTT solution, 5 μl of the PMS stock was added and then 0.25 ml of the XTT:PMS stock was added to 1-ml media to prepare the working XTT:PMS solution.
Following incubation for 1 h with lemongrass EO or citral, the medium containing the compounds was discarded and the cells were washed twice with PBS before incubation with 100 μl of the working XTT:PMS solution. Cells were incubated in the XTT:PMS reagent for 4 h and the absorbance read at 490 and 690 nm on a microtitre plate reader (BMG FLUOstar Omega). Each experiment was performed in quadruplicate on three separate occasions.
Controls included wells containing medium alone without cells (MA) and wells containing cells treated with medium alone without lemongrass EO or citral. For wavelength correction (corrects for optical imperfections), absorbance readings at 690 nm were first subtracted from the 490-nm readings. The data set was then blank corrected against the MA wells. The percentage viability was calculated as follows:
Data analysis and statistics
The cytotoxicity expressed as IC50 (the concentration that caused 50 % cell death) was calculated by a four-parameter non-linear regression using GraphPad Prism software by plotting the percentage viability against the log of the oil concentration. The t test was used to compare the means of both test compounds whilst a linear regression analysis was used to correlate the cytotoxic activity of the major component (citral) to the lemongrass EO.
Live cell imaging
HDF cells were imaged using the LumaScope 500 (Etaluma; Labtech, East Sussex, UK), which allows live cell imaging within a standard incubator. A ×40 objective lens was used under phase contrast settings. Images were acquired every minute for 120 min.
Gas chromatography mass spectroscopy
Chemical analysis of the lemongrass and grapeseed EO was performed using the Agilent 6890 N Gas Chromatograph system (Agilent Technologies, USA) instrument with a HP-5 column (0.25 mm × 30 m × 0.25 μm) and an Agilent Technologies 5973 inert MS detector with MSD. Column: Agilent 190,915–433 capillary, 0.25 mm × 30 m × 0.25 μm. Capillary: 30 m × 250 μm × 0.25 μm nominal. The oven temperature program was the following: initial temperature of 50 °C, increasing by 15 °C/min to 240 °C, and held for 30 min. The samples were dissolved in hexane, and helium was used as the carrier gas with a 1 μl injector volume, an injector temperature of 300 °C and a split ratio 20:1. The injector and detector temperature were held at 280 °C. The resulting compounds were identified by comparing retention times and mass spectra with those of standards or their retention indices (RI) with published data and their mass spectra with the National Institute of Standards and Technology (NIST) library.
Statistical analysis was conducted using GraphPad Prism 6. Significance levels were set at P = 0.05. Where the means of two samples were compared, the two-tailed t test was used and where the mean from more than two samples were compared, the one way analysis of variance (ANOVA) was applied.
The A. baumannii isolates were screened for antimicrobial susceptibility following exposure to antibiotics from four different antibiotic groups. The results showed that the ATCC® BAA-1709™ was the most sensitive of the isolates, followed by the NCTC 12156 (ATCC 19606), the ATCC® BAA-1710™, ATCC 17978 and the SM 37212 in that order. The ATCC 17978 was resistant to three of the four antibiotics and was only sensitive to the Piperacillin/Tazobactam combination whilst the SM 32712 was resistant to all the antibiotics tested Ciprofloxacin (Quinolones), Gentamicin (aminoglycosides), Meropenem (Carbapenem) and Piperacillin/Tazobactam (Beta-lactam/beta-lactamase inhibitor). Both the ATCC 17978 and the SM 37212 fit the criteria for MDR, i.e. non-susceptibility to ≥1 agent and in ≥3 antimicrobial categories (Magiorakos et al. 2012).
Disk diffusion assay results showed similar activity between whole lemongrass EO and citral (Fig. 1) although the activity of citral was slightly higher than that of whole lemongrass EO for three of the A. baumannii isolates (NCTC 12156, ATCC 17978 and SM 37212). The effect of both test compounds was significantly greater against the human isolate ATCC® BAA-1709™ (P = 0.02). This isolate was the most susceptible to the effects of the EO with full clearance of this organism on the agar plates following incubation, i.e. ZOI ≥ 86 mm. The other isolates demonstrated reduced susceptibility to both whole lemongrass EO and citral with inhibition zones between 15 and 28 mm for lemongrass EO and between approximately 22 and 27 mm for citral for the other tested strains.
The inhibitory and bactericidal activity of the EO and citral were determined using the broth micro dilution assay (Table 2). The minimum inhibitory concentration (MIC) for lemongrass was observed at a range between 0.25 and 1 % (v/v) whilst that for citral was between 0.06 and 0.25 % (v/v). The observed MIC was at a lower concentration when the organisms were exposed to citral then when exposed to the whole lemongrass EO. The MBC for lemongrass EO was between 0.5 and 2 % (v/v) for lemongrass EO and between 0.25 and 0.5 % (v/v) for citral. The highest combined MIC/MBC (least susceptible) was observed with the ATCC 1710 strain with MIC at 1 % (v/v) and MBC 2 % (v/v) when exposed to lemongrass EO although this was different with citral with the combined MIC/MBC of the least susceptible stain (NCTC 12156) at 0.25 % (v/v) and 0.5 % (v/v) for MIC and MBC, respectively (Table 2).
In all strains, the MIC determined following exposure to citral was lower than that for the whole lemongrass EO and with the exception of the NCTC 12156 strain with the MBC at 0.5 % (v/v), the MBC for the four other strains were lower than that of the lemongrass EO (Table 2).
Following exposure of the HDF cells to varying concentrations of lemongrass EO, cell viability was maintained between 80 and 100 % at 0.06 % (v/v) and the lower dilutions (Fig. 2). At 0.125 % (v/v), cell viability was approximately 60 % and at 2× the concentration, i.e. 0.25 % (v/v) the cell viability was approximately 25 %. At the tested concentrations higher than 0.25 % (v/v), exposure to lemongrass EO reduced the viability of the HDF cells to approximately 5 %.
When the HDF cells were exposed to citral at the same concentration ranges as the lemongrass EO, at the lowest concentrations between 0.008 and 0.016 % (v/v), there was no effect on cell viability. At 0.03 % (v/v), the cell viability was maintained between 80 and 100 %; however, at 0.06 % (v/v) the cell viability was approximately 75 %. At 0.125 % (v/v), the cell viability was reduced to approximately 42 %. At the higher concentrations ≥0.25 % (v/v), no viable cells were observed (Fig. 2).
The IC50 value obtained for lemongrass EO with the HDF was approximately 0.13 % (v/v) which was slightly higher than the IC50 of citral at approximately 0.1 % (v/v) (Table 1). Using two-tailed t test (two-tailed), the means of both lemongrass EO and citral EO were compared and the difference was not significant (P = 0.8254; R 2 = 0.003132). Grapeseed oil (the carrier oil) had no cytotoxic effects on the dermal fibroblasts and was therefore statistically different to the effects of both Lemongrass EO and citral (one way ANOVA; P = 0.0107; R2 = 0.3147).
The HDF cells prior to exposure with lemongrass or citral are shown in Fig. 3. When the HDF cells were exposed to lemongrass EO at 1 % (v/v) or citral at 0.25 % (v/v), changes in cell morphology were observed during the 120-min exposure. Within 5 min of citral exposure, the HDFs showed no noticeable changes; however, following 10 min, there was rounding up of cells. Following 20 min, there was a noticeable increase in the rounding up of cells and subsequent visible necrosis and cell death within 60 min (Fig. 4). Similarly, lemongrass EO also induced the rounding up of the cells following 10 min, with an increase following 20 min. Necrosis and presence of loosely attached cells was observed at 30, 60 and 120 min (Fig. 4).
A. baumannii has been described as AMR bacterium, and in this study, the isolates and type strain investigated for antimicrobial susceptibility to antibiotics demonstrated a range of susceptibilities to the different antibiotic groups tested (Table. 1). In 4/5 A. baumannii tested in this study, antibiotic resistance was identified and we observed varying resistance characteristics based on the criteria defined by Magiorakos et al. (2012). This included MDR in the ATCC 17978, PDR in the clinical isolate SM 37212 and possibly XDR in the ATCC BAA-1710™ isolate; however, further screening will confirm if this is a MDR or an XDR isolate. Following antibiotic screening, the isolates were exposed to lemongrass EO and major component (citral—approximately 90 % determined by GC-MS; Table 3) and found to be susceptible, including the isolates identified as MDR.
We observed that the human isolate ATCC BAA-1709™ was most sensitive to the antibiotics tested in this study and subsequently the most sensitive to the effects of both lemongrass EO and citral. Although it is difficult to make direct comparisons between the activity of the antibiotics and the EO/citral, the results suggest some similarity in level of activity between the different compounds. Other studies that have investigated activity of EOs and antibiotics have predominantly focused on the synergistic action (Rosato et al. 2007; Duarte et al. 2012; Aleksic et al. 2014 ) rather than any comparisons between both compound types. However, there is a need for further research into how the effects of lemongrass EO and/or citral relate to the effect of antibiotics on drug sensitive and resistant bacteria. The MIC and MBC results suggest that the effect of citral is greater than that of whole lemongrass EO. This was observed previously in Adukwu et al. (2012) where the inhibitory and bactericidal concentrations of citral were also lower against different isolates of S.aureus further indicating that pure citral is more potent than whole lemongrass EO against different bacteria species.
Following determination of antimicrobial activity, we analysed the effect of the EO/citral on dermal fibroblasts.
In the study by Kpoviessi et al. (2014), the authors found that only C. citratus demonstrated a moderately toxic activity against the W138 cells (IC50 = 39.77 μg/ml) whilst the other Cymbopogon species had low cytotoxicity against same fibroblast cells and suggested the need for further toxicity studies. The authors also found that citral, approximately 75 % from GC-MS analysis in their study, also demonstrated a moderately toxic activity (IC50 = 39.48 μg/ml).
In our study, following exposure of the dermal fibroblast cells to lemongrass EO at the concentration 0.125 % (v/v), cell viability was reduced to approximately 60 %, and at 0.25 (v/v), cell viability was reduced to approximately 25 %. At 0.125 % (v/v), the effect of citral on cell viability was approximately 15–16 % greater than the activity of whole lemongrass EO on the fibroblast cells, and at 0.25 % (v/v), there was total loss in cell viability at the 1-h exposure time. There was no loss in cell viability at ≤0.03 % for lemongrass EO although following exposure to citral at the same concentration, there was approximately a 15 % loss in cell viability. Overall, comparing the effect of both whole lemongrass EO and citral the observation is that the difference in cytotoxic activity at the concentrations tested is approximately 20 % thus, suggesting that as the concentration is increased, the cytotoxicity of citral increases in favour of citral.
This is not the first time that the cytotoxic effects of EO components has been observed to be greater than the whole oil. In Hammer et al. (2006), the components of TTO were shown to be more cytotoxic against human cells lines in comparison to whole TTO. A similar response was found in the study by Prashar et al. (2004) which showed that both linalool and linalyl acetate (major components in lavender accounted for approximately 85 % of the oil) were more cytotoxic than the whole EO. In contrast, Hayes and Markovic (2002) showed similar cytotoxic action (similar IC50 results) and no significant difference when citral was compared with the Australian lemon myrtle EO. This is similar to the findings in our study as there was no significant difference between the IC50 of whole lemongrass EO and citral (P = 0.8254) and although the oils are different, the concentration of citral in our study (>89 % v/v) from GC-MS analysis (Table 3) was similar to the citral content in the Hayes and Markovic study (>92 % v/v).
Recommendations by the Nomenclature Committee on Cell Death (NCCD) are that at least two distinct methods of assessments should be used for cell death analysis (Kroemer et al. 2009), and in a follow-up paper by Galluzzi et al. (2009) on guidelines for use and interpretation of cell death assays, using methods such as enzymatic assays which involve the incorporation of exclusive dyes and long-term survival assays could be fundamental in answering the questions surrounding cell death as described by the NCCD. In this study, we used the XTT assay, now a common tool used in cell viability assays (Berridge et al. 2005) for determining the effect of the test compounds on cell survival and the live cell imaging for morphological examinations of the treated HDF.
Morphological examinations of the treated HDF showed that both lemongrass EO (1 % v/v) and citral (0.25 % v/v) caused damage to the fibroblasts within the first few minutes and total cell death within the 120-min exposure time at the tested concentrations. Close examination of the fibroblasts treated by lemongrass EO showed possible cell damage with features such as rounding up of the cells, cell shrinkage and retraction of the pseudopods suggesting damage as a result of apoptosis. The citral-treated fibroblasts showed an increased amount of blebbing (spherical membrane protrusions), cell retraction and shrinkage suggesting apoptosis as well as necrotic features on the damaged fibroblasts (Leverrier and Ridley 2001; Charras and Paluch 2008). The morphological changes and damage observed at the tested concentrations support the cell viability results which suggest lack of metabolic activity linked to the inhibition of cell proliferation thus cell damage and cell death features. To support the morphological observations, future studies would benefit from assessments to determine apoptotic and/or necrotic activity such as caspase activation and nuclear fragmentation assays as recommended by the NCCD (Kroemer et al. 2009) Also, further tests on cytotoxicity using this species of lemongrass in vitro and in vivo is needed on different cell lines before deciding whether or not to use this EO for management of human topical infections.
In summary, we have shown that lemongrass EO and citral were effective at inhibiting and killing MDR A. baumannii. This enhances the potential of the lemongrass EOs as a possible alternative to antibiotics owing to its ability to effectively inhibit and kill both MDR Gram-positive and Gram-negative bacteria. Our study also demonstrate that at concentrations shown to be bactericidal against Gram-negative drug-resistant A. baumannii, whole lemongrass EO and citral act against dermal fibroblast cells in vitro. However, at concentrations where citral and whole lemongrass EO were previously shown to be inhibitory and bactericidal against drug-resistant MRSA and MSSA (Adukwu 2013, PhD thesis), cell viability of the HDF cells remain high (≥70 %) which is a positive finding as it offers the potential for of these use in managing contamination in both clinical and non-clinical settings where drug-resistant staphylococcal infections remains a major problem globally.
Adukwu EC 2013. Ph.D. thesis. University of Northampton, Northampton, UK.
Adukwu EC, Allen SC, Phillips CA (2012) The anti-biofilm activity of lemongrass (Cymbopogon flexuosus) and grapefruit (Citrus paradisi) essential oils against five strains of Staphylococcus aureus. J Appl Microbiol 113(5):1217–1227
Aleksic V, Mimica-Dukic N, Simin N, Nedeljkovic NS, Knezevic P (2014) Synergistic effect of Myrtus communis L. essential oils and conventional antibiotics against multi-drug resistant Acinetobacter baumannii wound isolates. Phytomedicine 21(12):1666–1674
Berridge MV, Herst PM, Tan AS (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 11:127–152
BSAC methods for antimicrobial susceptibility testing, Version 13 June 2014.http://bsac.org.uk/wp-content/uploads/2014/06/BSAC-disc-susceptibility-testing-method-June-2014.pdf. (Last accessed January 2015).
Charras G, Paluch E (2008) Blebs lead the way: how to migrate without lamellipodia. Nature Rev Mol Cell Biol 9(9):730–736
Doran AL, Morden WE, Dunn K, Edwards-Jones V (2009) Vapour-phase activities of essential oils against antibiotic sensitive and resistant bacteria including MRSA. Lett Appl Microbiol 48:387–392
Duarte A, Ferreira S, Silva F, Domingues FC (2012) Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii. Phytomedicine 19(3):236–238
Food and drug Administration (21CFR182.20). 2015a. Title 21, Vol 3. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr = 182.20. Accessed October 2015.
Food and drug Administration (21CFR182.20). 2015b. Title 21, Vol 3. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr = 182.20. Accessed October 2015.
Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE (2009) Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 16(8):1093–1107
Hammer KA, Carson CF, Riley TV, Nielsen JB (2006) A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol 44(5):616–625
Hayes AJ, Markovic B (2002) Toxicity of Australian essential oil Backhousia citriodora (lemon myrtle). Part 1. Antimicrobial activity and in vitro cytotoxicity. Food Chem Toxicol 40(4):535–543
Heydorn S, Menné T, Andersen KE, Bruze M, Svedman C, White IR, Basketter DA (2003) Citral a fragrance allergen and irritant. Contact Dermatitis 49:32–36
Kpoviessi S, Bero J, Agbani P, Gbaguidi F, Kpadonou-Kpoviessi B, Sinsin B, Accrombessi S, Frédérich M, Moudachirou M, Quetin-Leclercq J (2014) Chemical composition, cytotoxicity and in vitro antitrypanosomal and antiplasmodial activity of the essential oils of four Cymbopogon species from Benin. J Ethnopharmacol 151(1):652–659
Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16(1):3–11
Kumar P, Mishra S, Malik A, Satya S (2013) Housefly (Musca domestica L.) control potential of Cymbopogon citratus Stapf.(Poales: Poaceae) essential oil and monoterpenes (citral and 1, 8-cineole). Parasitol Res 112(1):69–76
Leverrier Y, Ridley AJ (2001) Apoptosis: caspases orchestrate the ROCK ‘n’ bleb. Nat Cell Biol 3(4):91–92
Lis-Balchin M, Hart SL, Deans SG (2000) Pharmacological and antimicrobial studies on different tea-tree oils (Melaleuca alternifolia, Leptospermum scoparium or Manuka and Kunzea ericoides or Kanuka), originating in Australia and New Zealand. Phytother Res 14(8):623–629
Loughlin R, Gilmore BF, McCarron PA, Tunney MM (2008) Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells. Lett Appl Microbiol 46:428–433
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol and Infect 18:268–281
Marongiu B, Piras A, Porcedda S, Tuveri E (2006) Comparative analysis of the oil and supercritical CO(2) extract of Cymbopogon citratus Stapf. Nat Prod Res 20(5):455–459
Nielsen JB (2008) What you see may not always be what you get—bioavailability and extrapolation from in vitro tests. Toxicol in Vitro 22(4):1038–1042
Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA (2007) Global challenge of multidrug-resistant Acinetobacter baumannii. Ant Agents Chemother 51(10):3471–3484
Prashar A, Locke IC, Evans CS (2004) Cytotoxicity of lavender oil and its major components to human skin cells. Cell Prolif 37:221–229
Rosato A, Vitali C, De Laurentis N, Armenise D, Milillo MA (2007) Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin. Phytomedicine 14(11):727–732
Söderberg TA, Johansson A, Gref R (1996) Toxic effects of some conifer resin acids and tea tree oil on human epithelial and fibroblast cells. Toxicology 107(2):99–109
Tisserand R, Balacs T (1995) Essential oil safety: a guide for health care professionals, 1st edn. Churchill Livingstone
Tisserand R, Young R (2013) Essential oil safety: a guide for health care professionals, 2nd edn. Livingstone, Churchill
Vila J, Pachón J (2011) Acinetobacter baumannii resistant to everything: what should we do? Clin Microbiol Infect 17:955–956
Warnke PH, Becker ST, Podschun R, Sivananthan S, Springer IN, Russo PA, Wiltfang J, Fickenscher H, Sherry E (2009) The battle against multi-resistant strains: renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections. J Cranio Maxill Surg 37(7):392–397
The author would like to thank the Society for Applied Microbiology (SfAM) for the Student Into Work Grant to support Melissa Bowles on summer internship during the period of this project. Many thanks also to Dr Gillian Smith and Dr Lee Graham, microbiology laboratory technical managers for supportive technical assistance throughout the project.
Conflict of interest
The authors declare that they have no conflicts of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
About this article
Cite this article
Adukwu, E.C., Bowles, M., Edwards-Jones, V. et al. Antimicrobial activity, cytotoxicity and chemical analysis of lemongrass essential oil (Cymbopogon flexuosus) and pure citral. Appl Microbiol Biotechnol 100, 9619–9627 (2016). https://doi.org/10.1007/s00253-016-7807-y
- Acinetobacter baumannii
- Lemongrass oil
- Multi-drug resistance (MDR)